Here, the protocol describes how to perform double labeling immunofluorescence using primary antibodies raised in the same species to study host-pathogen interactions. Also, it can include the third antibody from a different host in this protocol. This approach can be made in any cell type and pathogens.
Nowadays, it is possible to find a wide range of molecular tools available to study parasite-host cell interactions. However, some limitations exist to obtain commercial monoclonal or polyclonal antibodies that recognize specific cell structures and proteins in parasites. Besides, there are few commercial antibodies available to label trypanosomatids. Usually, polyclonal antibodies against parasites are prepared in-house and could be more challenging to use in combination with other antibodies produced in the same species. Here, the protocol demonstrates how to use polyclonal and monoclonal antibodies raised in the same species to perform double labeling immunofluorescence to study host cell and pathogen interactions. To achieve the double labeling immunofluorescence, it is crucial to incubate first the mouse polyclonal antibody and then follow the incubation with the secondary mouse IgG antibody conjugated to any fluorochrome. After that, an additional blocking step is necessary to prevent any trace of the primary antibody from being recognized by the next secondary antibody. Then, a mouse monoclonal antibody and its specific IgG subclass secondary antibody conjugated to a different fluorochrome are added to the sample at the appropriate times. Additionally, it is possible to perform triple labeling immunofluorescence using a third antibody raised in a different species. Also, structures such as nuclei and actin can be stained subsequently with their specific compounds or labels. Thus, these approaches presented here can be adjusted for any cell whose sources of primary antibodies are limited.
To study the interaction of the pathogen with the host cell at the cellular level provides essential information on the underlying causes of the disease since different groups, such as viruses, bacteria, and protozoa, can infect most host cell types1,2,3,4. It can also help develop and identify potential therapeutic targets that can slow or inhibit the growth of the pathogen. In live conditions, the produced antibodies are responsible for recognizing self-components, antigens from viruses, bacterial components or products, fungi, parasites, and others5.
For this purpose, antibodies are widely used tools, mainly for understanding the location and function of cellular structures and proteins. Several studies using multiple antibody labeling demonstrate that additional blocking steps contribute to the specificity of the immunolocalization. In addition, most described protocols use specific commercial monoclonal antibodies, including antibodies from the same host species6,7,8,9,10,11,12,13,14.
Usually, double labeling immunofluorescence uses two antibodies raised in different species to stain the cell structures of interest or the pathogens and the host cells to see the interaction between them. However, this can be a problem when no commercial monoclonal or polyclonal antibodies specific for some pathogens are available to perform the double labeling. Also, there are commercially available antibody conjugation kits, and it is possible to conjugate the primary antibodies directly to the fluorophore by a succinimidyl ester reaction15. The problem is that these kits are often expensive, and it is necessary to have enough antibodies to label them. Knowing this, we successfully developed a double immunofluorescence method using two different antibodies raised in the same species to study protein localization in Trypanosoma brucei16. However, for intracellular parasites, including Trypanosoma cruzi, this approach has not been demonstrated. Here, we show how to perform double labeling immunofluorescence to study intracellular T. cruzi parasites and the host cell using primary antibodies raised in the same species without cross-reactions. Besides this method, a triple immunofluorescence labeling has been established with the addition of the third antibody from a different species. These approaches help when the source of antibodies is limited and can be used in any cell type.
1. Cell and parasite cultures
2. Control immunofluorescence protocol
NOTE: Once fixed, it is possible to store plates containing coverslips at 4 °C in 1x PBS (pH 7.2) for one week. To be stored, it is important that the cells have not gone through the permeabilization step.
3. Double labeling immunofluorescence protocol using monoclonal and polyclonal antibodies raised in the same host
4. Triple labeling immunofluorescence protocol with the addition of the third polyclonal antibody from different host species
NOTE: For the additional labeling, note the IgG subclasses, antibody isotypes, and follow the order of antibodies: 1. mouse polyclonal, 2. rabbit polyclonal, 3. second block, and 4. mouse monoclonal. Consider the type of lasers available in the confocal microscope to choose the correct fluorophore-conjugated secondary antibody.
5. Confocal imaging acquisition
Here, we show how to study host-parasite interactions by immunofluorescence when the source of antibodies is limited due to the unavailability of commercial antibodies that recognize specific structures and proteins in trypanosomatids.
Among trypanosomatids, T. cruzi has one of the most complex life cycles involving various development stages between vertebrate and invertebrate hosts 19. During the T. cruzi life cycle, at an early stage of mammalian infection, metacyclic trypomastigotes invade cells through a process that involves a wide variety of molecules present in parasites and the vertebrate host cells 19,20. To study these processes, our laboratory routinely produces in-house polyclonal antibodies against proteins of T. cruzi, T. brucei, and Leishmania sp16,21,22,23 to use together with commercial mouse monoclonal antibodies and/or with rabbit antibodies.
In Figure 1, confocal microscopy images show the results with the control experiments of infected and non-infected cells, highlighting the specificity of the antibodies in the host cell and the internalized parasite. The mouse polyclonal antibody (anti-TcFAZ) raised in our lab recognized only T. cruzi giant protein in the FAZ at the parasite flagellum but not in the host cell (Figure 1A). The distribution of the heterogeneous nuclear ribonucleoprotein A124 in the nuclei was observed using a commercial mouse monoclonal anti-hnRNP A1 antibody that recognizes only the host mammalian cells but not the parasite (Figure 1B). Also, host and parasite nuclei and the parasite kinetoplasts were stained with DAPI, and host F-actin was stained with Phalloidin conjugated to Alexa 594 (Figure 1). These control results show the specificity of the antibodies, and then, we can run the double labeling immunofluorescence protocol (Figure 2).
In Figure 2, double labeling immunofluorescence shows the protein distributions in the host and the parasite analyzed by confocal microscopy. No cross-reactions occur between antibodies using this methodology. The efficiency of the second blocking step using purified rabbit anti-mouse IgG is enough to impair the nonspecific labeling by the secondary antibodies. This labeling allows studying the interaction between the parasite and the host proteins and their behavior during infection.
Figure 1: Confocal Microscopy showing the localization of the T. cruzi giant protein (TcFAZ) and host hnRNP A1 in non-infected (NI) and infected (INF) LLC-MK2 cells with T. cruzi. (A) T. cruzi giant protein (TcFAZ) localized in T. cruzi flagellum is labeled with mouse polyclonal anti-TcFAZ antibody and visualized with the goat anti-mouse IgG secondary antibody conjugated to Alexa 488 (green). (B) Host nuclear hnRNP A1 in LLC-MK2 is labeled with mouse monoclonal anti-hnRNP A1 IgG2b antibody and visualized by goat anti-mouse IgG2b antibody conjugated to Alexa 488 (green). Phalloidin conjugated to Alexa 594 stains F-actin (red). Nuclei and kinetoplasts are stained with DAPI (blue). Scale bar = 5 µm. All experiments were made in biological triplicate. White arrows indicate intracellular parasites. Please click here to view a larger version of this figure.
Figure 2: Double labeling immunofluorescence shows no-cross reaction between antibodies raised in the same host species in non-infected (NI) and infected (INF) LLC-MK2 cells with T. cruzi analyzed by Confocal Microscopy. Giant protein localized in the flagellum attachment zone (FAZ) is labeled with mouse polyclonal anti-TcFAZ antibody and visualized by goat anti-mouse IgG antibody conjugated to Alexa 647 (red). Host nuclear hnRNP A1 is labeled with mouse monoclonal anti-hnRNP A1 IgG2b antibody and visualized by goat anti-mouse IgG2b antibody conjugated to Alexa 488 (green). Phalloidin conjugated to Alexa 594 stains F-actin (grey). Nuclei and kinetoplasts are stained with DAPI (blue). Merged images are shown as indicated. Inset corresponds to the enlarged area of the host nucleus. Bar=5 µm. All experiments were made in biological triplicate. The white arrow shows the presence of the parasite near the host cell nucleus. Please click here to view a larger version of this figure.
Figure 3: Schematic illustration of sequential double immunostaining with primary antibodies derived from the same species. Diagram shows the order of the antibodies to ensure the efficiency of this protocol. Please click here to view a larger version of this figure.
Here, we present a protocol to perform double immunolabeling in Trypanosoma cruzi infected cells using two different antibodies from the same host species. To study, with more detail, the implications of the infection, structures in the host cell such as the nucleus or cytosolic organelles can be labeled using this protocol. Also, it can be used in the post-embedding thin section immunogold labeling method. This approach helps to overcome the obstacle of having few antibodies available to study trypanosomatids and other parasites.
Additionally, our protocol showed an intracellular parasite is labeled together with the host cell, two eukaryotes in the same immunofluorescence, different from those protocols realized in different kinds of tissues7,8,9,10,11,12,13,14. Our protocol shows that no epitope of the primary polyclonal antibody can be recognized by the second secondary antibody (step 3.9), ensuring that no cross-reactions occur between the antibodies (Figure 3). The success of this methodology is due to the efficiency of the blocking step (step 3.6) using purified rabbit anti-mouse IgG. A similar protocol described by Ansorg et al. (2015) has two additional blocking, where the first uses serum from the same host as the primary antibody and the second is realized with unconjugated Fab-fragments6. Also, without the second blocking, false-positive labeling can occur, as explained by these authors 6.
Furthermore, for triple immunolabeling, the third antibody of a rabbit host species can be added before the second blocking step described above in the protocol (step 4.2). Also, it is possible to use more than one monoclonal antibody since they have different IgG subclasses. For this, the corresponding secondary antibodies should be highly adsorbed to minimize cross-reactivity between them. The use of different IgG subclasses allows the utilization of the same host antibodies without cross-reaction. These protocols work well, but control groups are necessary to avoid false-positive results. The specificity of IgG subclasses and their properties makes it possible to do double and triple labeling. It has been reported that the IgG subclasses differ in the complement activation and Fc receptors in the inter-heavy chain disulfide bonds, hinge region amino acids, molecular mass (kDa), and the relative abundance (in percentage) in response to proteins, saccharides, and allergens 25. They have slight differences in the hinge structure amino acids, influencing the stability and flexibility of each IgG subclass. IgG2 has the shortest and even more rigid hinge of all IgG subclasses due to a CH2 region with one amino acid deletion and an extra inter-heavy chain disulfide bridge 25.
In summary, the protocol described here to study host-pathogen interactions presents a basic and elaborated technique adapted to any combination of antibodies. This approach makes immunofluorescence cost-effective and can help when the source of antibodies is limited. The protocol can simultaneously detect pathogens and the host cell proteins in infected host cells; it can also be applied to any cell type and free-living organisms.
The authors have nothing to disclose.
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2010/19547-1; 2018/03677-5) to MMAB, by Fundação de Apoio ao Ensino, Pesquisa e Assistência- FAEPA to MMAB and by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior- Brasil (CAPES) – finance code 001. CG-C received a master and doctoral fellowship from CAPES and LAMT-S received doctoral fellowship from CNPq. We thank Elizabete R. Milani for confocal microscopy assistance and Dr. Dario Zamboni for providing LLC-MK2 cells (Ribeirao Preto Medical School, USP).
Alexa Fluor 488 – IgG2b antibody | Life technologies, USA | A21141 | Goat anti-mouse |
AffiniPure Rabbit anti-mouse IgG (H+L) | Jackson Immunoresearch, USA | 315-005-003 | Anti-mouse antibody |
Alexa Fluor 488 – IgG F (ab')2 (H+L) antibody | Life technologies, USA | A11017 | Goat anti mouse |
Alexa Fluor 594 IgG1 antibody | Life technologies, USA | A21125 | Goat anti-mouse |
Alexa Fluor 647 – IgG F (ab')2 (H+L) antibody | Life technologies, USA | A21237 | Goat anti-mouse |
Anti-hnRNPA1 antibody IgG2b | Sigma-Aldrich, USA | R4528 | Mouse antibody |
anti-TcFAZ (T. cruzi FAZ protein) antibody | Our lab | In-house | Mouse antibody |
Bovine Serum Albumin (BSA) | Sigma-Aldrich, USA | A2153-10G | Albumin protein |
Detergent Igepal CA-630 | Sigma-Aldrich, USA | I3021 | Nonionic Detergent |
Fetal Bovine Serum (FBS) | Gibco, Thermo fisher scientific, USA | 12657-029 | Serum |
Penicillin Streptomycin | Gibco, Thermo fisher scientific, USA | 15140-122 | Antibiotic |
Phalloidin Alexa Fluor 594 | Life technologies, USA | A12381 | Actin marker |
ProLong Gold antifade with DAPI | Life technologies, USA | P36935 | Mounting media reagent |
RPMI 1640 1X with L-glutamine | Corning, USA | 10-040-CV | Cell culture media |
Trypsin-EDTA solution | Sigma-Aldrich, USA | T4049-100ML | Bioreagent |